Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Sherman

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanomaA A Jakubowski, D F Bajorin, M A Templeton, et al.
Annals of the New York Academy of Sciences|October 12, 2001
The role for interleukin-12 therapy of cutaneous T cell lymphomaA H Rook, M H Zaki, M Wysocka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignanciesM B Atkins, M J Robertson, M Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapseE L Sievers, R A Larson, E A Stadtmauer, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanomaA A Jakubowski, D F Bajorin, M A Templeton, et al.
Annals of the New York Academy of Sciences|October 12, 2001
The role for interleukin-12 therapy of cutaneous T cell lymphomaA H Rook, M H Zaki, M Wysocka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignanciesM B Atkins, M J Robertson, M Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapseE L Sievers, R A Larson, E A Stadtmauer, et al.
Pageof 8